Related Experiment Video
Updated: May 15, 2025

16:18
Microfluidic Device for Recreating a Tumor Microenvironment in Vitro
Published on: November 20, 2011
11.5K
The solid tumor microenvironment and related targeting strategies: a concise review
Yingliang Wang1,2,3, Huimin Zhou4, Shuguang Ju1,2,3
1Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Frontiers in Immunology
|April 10, 2025
Summary
This study classifies the tumor microenvironment (TME) into physical, mechanical, metabolic, inflammatory, and immune components. Understanding these TME characteristics is crucial for developing new cancer therapies.
Area of Science:
- Oncology
- Cancer Biology
- Immunology
Background:
- The tumor microenvironment (TME) critically influences tumor progression, including proliferation, apoptosis resistance, immune evasion, and metastasis.
- Despite its importance, a deep understanding of TME component characteristics and their interrelationships is lacking.
- Targeting the TME requires comprehensive knowledge of its constituents and their roles in tumor growth.
Purpose of the Study:
- To innovatively classify the TME into distinct physical, mechanical, metabolic, inflammatory, and immune microenvironments.
- To elucidate the characteristics of each TME component and their detection methods.
- To highlight current therapeutic strategies, potential targets, challenges, and future directions for TME research.
Main Methods:
- Classification of the TME into five key categories: physical, mechanical, metabolic, inflammatory, and immune.
- Depiction of the characteristics of individual TME components.
- Summary of current detection methodologies for TME constituents.
- Review of existing and potential therapeutic strategies targeting the TME.
Main Results:
- A novel, comprehensive classification system for the TME is introduced.
- Detailed descriptions of the characteristics of physical, mechanical, metabolic, inflammatory, and immune microenvironments are provided.
- Current strategies and potential therapeutic targets within the TME are highlighted.
Conclusions:
- A deeper understanding of TME components and their interactions is essential for effective cancer therapy.
- The proposed classification provides a framework for future research and clinical applications of TME-targeted treatments.
- Addressing current challenges in TME research will unlock significant clinical benefits and advance cancer treatment strategies.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Tumor Immunotherapy
411
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
411
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K

